Overview
Aurelien Serandour practices in Nantes, France. Serandour is rated as an Advanced expert by MediFind in the treatment of RUNX1 Familial Platelet Disorder. Their top areas of expertise are RUNX1 Familial Platelet Disorder, Acute Lymphoblastic Leukemia (ALL), Glioblastoma, and Astrocytoma.
Their clinical research consists of co-authoring 25 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of RUNX1 Familial Platelet Disorder.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RUNX1 Familial Platelet Disorder
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Serandour isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- AstrocytomaSerandour isExperienced. Learn about Astrocytoma.
- Breast CancerSerandour isExperienced. Learn about Breast Cancer.
- GlioblastomaSerandour isExperienced. Learn about Glioblastoma.
- GliomaSerandour isExperienced. Learn about Glioma.
- LeukemiaSerandour isExperienced. Learn about Leukemia.